Isolation and characterization of endogenous modulators for GABA system.

Area of Science:

• Neuroscience
• Biochemistry
• Pharmacology

Background:

• Gamma-aminobutyric acid (GABA) is a primary inhibitory neurotransmitter in the central nervous system.
• Endogenous modulators of GABAergic neurotransmission are crucial for understanding brain function and dysfunction.

Purpose of the Study:

• To identify and characterize endogenous inhibitors of GABA synthesizing enzyme, glutamate decarboxylase (GAD), and GABA binding in pig brain extracts.
• To investigate the biochemical properties and potential mechanisms of action of these endogenous GAD inhibitors (EGIs) and muscimol binding inhibitors (MBIs).

Main Methods:

• Soluble and membrane fractions of pig brain extracts were prepared.
• Gel-filtration chromatography (Bio-Gel P-2) was used for purification of EGIs and MBIs.
• Characterization of EGIs and MBIs based on molecular weight, stability, charge, and hydrophobicity.
• Assessment of MBIs' effect on [3H]flunitrazepam binding to benzodiazepine receptors.

Main Results:

• Potent EGIs and MBIs were detected in pig brain extracts.
• Purification revealed multiple activity peaks, with some co-eluting with L-glutamate or GABA, while others were separated.
• EGIs are low molecular weight (<1,800 Da), heat and acid-base stable, negatively charged, and non-hydrophobic.
• MBIs are low molecular weight (<1,800 Da) and neutral or positively charged.
• MBIs did not affect [3H]flunitrazepam binding, suggesting specific action at the GABA binding site, not the benzodiazepine receptor.

Conclusions:

• Pig brains contain distinct endogenous low molecular weight substances that modulate GABAergic neurotransmission.
• EGIs and MBIs possess different physicochemical properties, indicating separate molecular entities.
• MBIs may act as specific ligands for the GABA binding site, distinct from benzodiazepine receptor interactions.